$32 a share from JNJ for Acadia. What do you all think? No one would want to buy ACAD right all the big pharma want ATRS
All the analysts I know say JNJ buys ACAD for $300.
Of course my analysts are like yours, a figment of imagination.
If you think ACAD is so great then why do you spend your time on the ATRS board?
Most of the longs on ATRS own ACAD. Not even a little bit of ACAD a majority of their portfolios are ACAD.
because with 90% institutional ownership the ACAD board is dead, and all these trolls would rather hang around on a board where they may get a response...